- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03349476
Model Based Fast Anatomical Mapping (MFAM)
Left Atrial Anatomy Reconstruction Using Model Based Fast Anatomical Mapping
Study Overview
Status
Intervention / Treatment
Detailed Description
This prospective, multicenter observational study will examine the ability of model based fast anatomical mapping (mFAM) to create left atrial (LA) geometry for atrial fibrillation ablation.
Specifically, the study will assess the following issues in atrial fibrillation ablation:
- Accuracy of map (defined as the distance between the ablation points and the surface of the mFAM geometry)
- Left atrial geometry creation time
- Fluoroscopy time
The clinical team will hypothesize that this approach will lead to accurate LA geometry creation more rapidly and using less fluoroscopy than standard techniques
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10029
- Icahn School of Medicine at Mount Sinai
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age ≥ 18 years
Have AF as follows:
- Paroxysmal AF - defined as AF that is non-sustained (terminate without electrical or pharmacologic cardioversion) lasting < 7 days.
- Persistent AF - defined as AF that is sustained > 7 days. Episodes of AF which are terminated by electrical or pharmacologic cardioversion after ≥ 48 hours of AF, but prior to 7 days, should also be classified as persistent AF episodes.
- Are planned to undergo a first catheter ablation procedure (prior typical atrial flutter is allowed)
- Have the ability to understand the requirements of the study and sign the informed consent form.
- Are willing to adhere to study restrictions and comply with all post-procedural follow-up requirements
Exclusion Criteria:
- Rheumatic heart disease,
- Current intra-cardiac thrombus
- Class IV HF
- Unable to sign consent
- Unstable angina
- Recent cerebral ischemic events
- Contradiction to anticoagulation
- Prior cardiac surgery
- Complex congenital heart disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: MFAM
The mFAM Workstation is a computerized system used to reconstruct the shape of the left atrium of the heart, by fitting a parametric shape model to points data acquired by a catheter. The mFAM Workstation uses recorded catheter positions and other data inputs collected from various types of multi-electrode catheters and generates output data files that can be displayed as a 3D anatomic structure. |
Specifically, the mFAM Workstation accesses stored data of recorded electronic heart activity that has been obtained by conventional electrophysiological methods, using multi-electrode catheters placed in the heart (data inputs) for collection. Using proprietary software algorithms, the mFAM Workstation analyzes these data inputs and generates 3D anatomical structure. mFAM improves on the FAM functionality by applying a model-based approach for reconstruction of left atrial chamber anatomy |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
mMap Scoring Questionnaire
Time Frame: hospital discharge, average 24 hours post procedure
|
mMap Scoring Questionnaire: Tool used by operators to rate the accuracy of the map based on the distance between ablation points and accuracy of anatomy compared to the mapped mFam geometry. Total score from 1-7, with lower score indicating not representing (misleading) and higher score indicating agreement (accurate) |
hospital discharge, average 24 hours post procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fluoroscopy Time
Time Frame: hospital discharge, average 24 hours post procedure
|
Fluoroscopy (radiation) time for left atrial anatomy creation during the ablation procedure
|
hospital discharge, average 24 hours post procedure
|
|
Left Atrial Geometry Creation Time
Time Frame: during the procedure up to 60 minutes
|
The amount of time it takes to create the geometrical map using Carto and MFAM during the ablation procedure
|
during the procedure up to 60 minutes
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Mohit Turagam, MD, Icahn School of Medicine at Mount Sinai
- Study Chair: Vivek Reddy, MD, Icahn School of Medicine at Mount Sinai
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-02-329
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Paroxysmal Atrial Fibrillation
-
Changhai HospitalNot yet recruitingParoxysmal Atrial Fibrillation | Paroxysmal Atrial Fibrillation (PAF)China
-
Shanghai MicroPort EP MedTech Co., Ltd.Not yet recruiting
-
Shanghai MicroPort EP MedTech Co., Ltd.Not yet recruitingParoxysmal Atrial Fibrillation (PAF)China
-
Boston Scientific CorporationCompletedParoxysmal Atrial Fibrillation (PAF)United States, Spain, Germany, Australia, United Kingdom, Sweden, Czechia, France, Portugal
-
Medtronic Cardiac Ablation SolutionsCompletedParoxysmal Atrial Fibrillation (PAF)United States, Canada
-
Universitair Ziekenhuis BrusselCompletedCardiac Arrhythmia | Paroxysmal Atrial Fibrillation (PAF) | Atril FibrillationBelgium, Italy, Croatia, Greece, Poland
-
Hospital Clinic of BarcelonaCompletedDrug-refractory Paroxysmal Atrial FibrillationSpain
-
Biosense Webster, Inc.CompletedDrug Refractory Paroxysmal Atrial FibrillationUnited States
-
Biosense Webster, Inc.CompletedDrug Refractory Symptomatic Paroxysmal Atrial FibrillationUnited States
-
CortexAblacon, Inc.Active, not recruitingAtrial Fibrillation | Arrhythmias, Cardiac | Arrhythmia | Atrial Flutter | Atrial Fibrillation, Persistent | Atrial Tachycardia | Atrial Arrhythmia | Atrial Fibrillation Paroxysmal | Atrial Fibrillation, Paroxysmal or PersistentUnited States, Belgium, Netherlands, Czechia